Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
76 0% |
 |
Gilead SciencesGILD |
55 0% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Mar 2025 | 33 | |
| Feb 2025 | 36 | |
| Jan 2025 | 31 | |
| Dec 2024 | 33 | |
| Nov 2024 | 33 |
How do employees feel about the future at Bluebird bio?
According to employees, the Business Outlook at Bluebird bio is highly negative. This is reflected in the average rating of 31 out of 100, which is considered very low. This rating (aggregated from the top review sites in the US) is also down by -6.1% since the previous month.
Analyzing Business Outlook, how is Bluebird bio performing compared to its industry peers?
Bluebird bio underperforms its industry peers when it comes to Business Outlook, ranking in the 31st percentile.
How has the business outlook at Bluebird bio changed over the last couple of months
There has been no meaningful change in the business outlook amongst employees at Bluebird bio.
Why is it important to track the business outlook at Bluebird bio?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Bluebird bio.
